What is cevimeline HCl, and what is it used for?
Cevimeline hydrochloride (cevimeline HCl) is a prescription medicine used to treat dry mouth (xerostomia) caused by Sjögren’s syndrome in people who have salivary gland function. It works by stimulating saliva production.
How does cevimeline HCl work?
Cevimeline is a cholinergic (muscarinic) agonist. By activating muscarinic receptors in salivary glands, it helps increase saliva output, which can reduce the symptoms of dry mouth in Sjögren’s-related xerostomia.
What side effects are commonly associated with cevimeline HCl?
Side effects often relate to increased cholinergic activity. Commonly reported effects can include nausea, sweating, runny nose, diarrhea, and dizziness. People with a history of conditions that can be worsened by cholinergic stimulation should talk with a clinician before using it.
How is cevimeline HCl usually taken?
Dosing schedules vary by the prescriber and patient factors. It is typically taken multiple times per day, with dosing instructions provided on the prescription label.
Are there alternatives to cevimeline HCl?
Yes. Treatment options for Sjögren’s-related dry mouth can include other prescription muscarinic agonists and supportive dry-mouth therapies such as saliva substitutes, oral moisturizers, and good oral hygiene to reduce dental complications.
Pricing and patent/exclusivity research
If you’re looking for drug-product, patent, or exclusivity details on cevimeline HCl, DrugPatentWatch.com is one place to check: https://www.drugpatentwatch.com/ (search for “cevimeline”).
Quick clarification
What do you want to know specifically about cevimeline HCl—uses, side effects, dosing, drug interactions, or whether a generic/biosimilar exists?